DiaCarta, Inc

DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. To learn more, visit http://www.diacarta.com

Precision molecular diagnostics,translational genomics,clia lab,xna technology,superbdna technology,ngs,liquid biopsy,cancer mutation detection,colorectal cancer mutation detection,in-vitro diagnostics,precision medicine,personalized radiation therapy,hpv mrna test,cervical cancer screening,head and neck cancer screening,early cancer detection,car-t and immuno therapy,and whole genome sequencing

Diacarta, inc operates in the Biotechnology industry.

Diacarta, inc's revenue is 11m - 100m

Diacarta, inc has 11 - 50 employees.